References
- Alvarez-Diez TM, Zheng J. (2004). Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol. Chem Res Toxicol 17:150–7
- An Editorial Committee of the Administration Bureau of Traditional Chinese Medicine. (1999). Chinese materia medica (Zhonghua Bencao). Shanghai, China: Shanghai Science & Technology Press
- Byrns MC, Predecki DP, Peterson LA. (2002). Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol 15:373–9
- Cao J, Zheng L, Ji L, et al. (2015). Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin. Chem–Biol Interact 226:23–9
- Chen L, Hecht SS, Peterson LA. (1997). Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol 10:866–74
- Evans WE, Relling MV. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–91
- Gu L, Wu T, Zhang Z, et al. (2006). Evaluation of antioxidant activity of Radix linderae and other two Chinese drugs using TLC-bioautography. Acta Pharm Sin 41:956–62
- Hutzler JM, Balogh LM, Zientek M, et al. (2009). Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/−)-suprofen: a comparison of kinetics and probe substrate selection. Drug Metab Dispos 37:59–65
- Kaminsky LS, Zhang Z. (1997). Human P450 metabolism of warfarin. Pharmacol Ther 73:67–74
- Khojasteh-Bakht SC, Koenigs LL, Peter RM, et al. (1998). (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab Dispos 26:701–4
- Klaassen CD, Amdur MO, Doull J. (1986). Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett and Doull’s toxicology, the basic science of poisons. New York: McGraw-Hill, 113–86
- Koenigs LL, Trager WF. (1998). Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry 37:10047–61
- Kunze KL, Trager WF. (1993). Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem Res Toxicol 6:649–56
- Kunze KL, Wienkers LC, Thummel KE, Trager WF. (1996). Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. Drug Metab Dispos 24:414–21
- Nagata M, Hidaka M, Sekiya H, et al. (2007). Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab Dispos 35:302–5
- Noda Y, Mori A. (2007). Antioxidant activities of Uyaku (Lindera strychnifolia) leaf extract: a natural extract used in traditional medicine. J Clin Biochem Nutr 41:139–45
- Ohno T, Nagatsu A, Nakagawa M, et al. (2005a). New sesquiterpene lactones from water extract of the root of Lindera strychnifolia with cytotoxicity against the human small cell lung cancer cell, SBC-3. Tetrahedron Lett 46:8657–60
- Ohno T, Takemura G, Murata I, et al. (2005b). Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice. Life Sci 77:1391–403
- Silverman RB. (1996). Mechanism-based enzyme inactivation. In: Purich DL, ed. Contemporary enzyme kinetics and mechanism. San Diego: Academic Press, 291–335
- Toon S, Low LK, Gibaldi M, et al. (1986). The warfarin–sulfinpyrazone interaction: stereochemical considerations. Clin Pharmacol Ther 39:15–24
- Ute MK, Jushchyshyn MI, Hollenberg PF. (2001). Mechanism-based inactivators as probes of cytochrome P450 structure and function. Curr Drug Metab 2:215–43
- Wang N, Minatoguchi S, Arai M, et al. (2004). Lindera strychnifolia is protective against post-ischemic myocardial dysfunction through scavenging hydroxyl radicals and opening the mitochondrial KATP channels in isolated rat hearts. Am J Chin Med 32:587–98
- Wu Y, Zheng Y, Liu X, et al. (2010). Separation and quantitative determination of sesquiterpene lactones in Lindera aggregata (Wu-yao) by ultra-performance LC-MS/MS. J Sep Sci 33:1072–8
- Zheng L, Cao J, Lu D, et al. (2015). Imperatorin is a mechanism-based inactivator of CYP2B6. Drug Metab Dispos 43:82–8